site stats

Ntla earnings

Web1 dag geleden · Intellia Therapeutics - NTLA - Stock Price Today - Zacks Intellia Therapeutics (NTLA) (Delayed Data from NSDQ) $34.96 USD -1.00 (-2.78%) Updated Apr 10, 2024 04:00 PM ET After-Market:... Web7 mei 2024 · Intellia Therapeutics, Inc. (NTLA 0.47%) Q1 2024 Earnings Call May 7, 2024, 8:00 p.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; …

Why Are Gene-Editing Stocks CRSP, EDIT, NTLA Stock Up Today?

Web31 mrt. 2024 · NTLA Overview Technical Chart Intellia Therapeutics Inc 34.96 -1.00 ( -2.78 %) Prev. Close 35.96 Day's Range 34.43 - 35.81 Revenue 52.12M Open 35.6 52 wk Range 32.44 - 76.45 EPS -6.16 Volume... Web17 mrt. 2024 · All earnings call transcripts on Intellia Therapeutics, Inc. (NTLA) stock. Read or listen to the conference call. Download the investor presentation - earnings call slides. goldbay paydirt review https://segatex-lda.com

NTLA Earnings Update (Intellia Therapeutics Stock) Complete …

WebThe current consensus among 28 polled investment analysts is to Buy stock in Intellia Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating. Move your... WebNTLA Earnings Forecast Next quarter’s earnings estimate for NTLA is -$1.40 with a range of -$1.70 to -$1.17. The previous quarter’s EPS was -$1.40. NTLA beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 54.36% of the time in the same period. Web6 apr. 2024 · In 2024, NTLA's revenue was $52.12 million, an increase of 57.69% compared to the previous year's $33.05 million. Losses were -$474.19 million, 77.0% more than in 2024. Financial Statements Analyst Forecast According to 35 analysts, the average rating for NTLA stock is "Buy." hbo max app para fire tv

NTLA Intellia Therapeutics Inc. Analyst Estimates & Rating – WSJ

Category:Intellia Therapeutics (NTLA) Stock Forecast & Price Target - TipRanks

Tags:Ntla earnings

Ntla earnings

What date does Intellia Therapeutics

Web13 apr. 2024 · Intellia Therapeutics (NASDAQ:NTLA – Get Rating) last released its quarterly earnings results on Thursday, February 23rd.The company reported ($1.40) EPS for the quarter, meeting the consensus estimate of ($1.40). Intellia Therapeutics had a negative net margin of 909.78% and a negative return on equity of 48.70%. WebIntellia Therapeutics, Inc. (NTLA) Stock Price, News, Quote & History - Yahoo Finance U.S. markets closed S&P 500 +14.64 Dow 30 33,485.29 +2.57(+0.01%) Nasdaq 12,087.96 …

Ntla earnings

Did you know?

Web13 apr. 2024 · Biogen last issued its quarterly earnings results on February 15th, 2024. The biotechnology company reported $4.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.48 by $0.57. The company earned $2.54 billion during the quarter, compared to analyst estimates of $2.44 billion. Web22 feb. 2024 · Intellia Therapeutics ( NASDAQ: NTLA) is scheduled to announce Q4 earnings results on Thursday, February 23rd, before market open. The consensus EPS …

Web12 apr. 2024 · Intellia Therapeutics (NASDAQ:NTLA) has a market capitalization of $3.17 billion and generates $52.12 million in revenue each year. The company earns $ …

Web21 mrt. 2024 · The Investor Relations website contains information about Intellia Therapeutics's business for stockholders, potential investors, and financial analysts. Intellia Therapeutics - investor relations. Web6 apr. 2024 · NTLA: Intellia Therapeutics Detailed Earnings Estimate. Get the latest Detailed Estimate from Zacks Investment Research. NTLA: Intellia Therapeutics - …

Web6 apr. 2024 · NTLA: Intellia Therapeutics Detailed Earnings Estimate. Get the latest Detailed Estimate from Zacks Investment Research.

Web8 apr. 2024 · Intellia Therapeutics last announced its quarterly earnings data on February 23rd, 2024. The reported ($1.40) EPS for the quarter, meeting analysts' consensus … gold bbc drama iplayerWebNTLA Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. gold baytown ms70WebNasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making … hbomax apps sign inWeb13 apr. 2024 · Intellia Therapeutics Inc. (NASDAQ:NTLA) shares, rose in value on Thursday, April 13, ... Analysts are projecting the company’s earnings per share (EPS) to be -$1.4, which is expected to increase to -$1.27 for fiscal year -$5.88 and then to about -$6.11 by fiscal year 2024. hbomax apps downloadWebIntellia Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NTLA updated stock price target summary. gold bayreuthWeb19 uur geleden · Fintel reports that on April 13, 2024, Canaccord Genuity initiated coverage of Intellia Therapeutics (NASDAQ:NTLA) with a Buy recommendation. As of April 6, 2024, the average one-year price target ... hbomax apps on lg tvWebIntellia Therapeutics (NTLA) will release its next earnings report on May 4, 2024. In the last quarter Intellia Therapeutics reported -$1.379 EPS in relation to -$1.4 expected by the market. hbo max app reviews